Skip to main content
Article thumbnail
Location of Repository

A systematic review of infliximab in the treatment of early rheumatoid arthritis

By Sophie Martin Du Pan, Cem Gabay and Axel Finckh
Topics: Review
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2376089
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2006). A meta-analysis on the timing of therapeutic introduction of infl iximab ( IFX) and etanercept (ETN).
    2. (1998). Aggressive treatment of early rheumatoid arthritis to prevent joint damage. Bull Rheum Dis,
    3. (1995). American college of rheumatology preliminary defi nition of improvement in rheumatoid arthritis. Arthritis Rheum,
    4. (2006). Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials.
    5. (2005). Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study):a randomized, controlled trial. Arthritis Rheum,
    6. (2002). College of Rheumatology.
    7. (2004). Combination of infl iximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum,
    8. (1999). Combination therapy in rheumatoid arthritis.
    9. (2004). Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infl iximab therapy in early rheumatoid arthritis. Arthritis Rheum,
    10. (2000). How to read radiographs according to the Sharp/van der Heijde method.
    11. (2006). Induction of remission in patients with early rheumatoid arthritis (RA) initially treated with either prednisone or infl iximab combination therapy [abstract]. Arthritis Rheum 54 (Suppl): S302 (abstract 658).
    12. (2000). Infl ammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: longterm course and association to radiographic progression.
    13. (2004). Infl iximab in active early rheumatoid arthritis. Ann Rheum Dis,
    14. (2006). Infl iximab treatment maintains employability in patients with early rheumatoid arthritis. Arthritis Rheum,
    15. (2003). Joint damage and disability in rheumatoid arthritis:an updated systematic review. Clin Exp Rheumatol, 21(5 Suppl 31):S20–7.
    16. (2006). LETTERS: Risk of serious infections and malignancies with anti-tnf antibody therapy in rheumatoid arthritis.
    17. (2006). Long-term impact of early aggressive treatment of rheumatoid arthritis. A metaanalysis. Arthritis Rheum, 55.
    18. (2006). Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infl iximab:results from the ASPIRE trial. Arthritis Rheum,
    19. (2001). Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann Rheum Dis,
    20. (1997). Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
    21. (2005). Reduced mortality among RA patients treated with anti-TNF therapy and methotrexate. EULAR Vienna, Dis. Ann Rheum Dis, 64(Suppl III):87.
    22. (1989). Remodeling the pyramid – a concept whose time has come.
    23. (2001). Rheumatoid arthritis. epidemiology of the rheumatic diseases. Silman AJ,
    24. (1988). The American Rheumatism Association
    25. (1998). The burden of rheumatoid arthritis: facts and fi gures.
    26. (2005). The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK.
    27. (2003). The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis
    28. (1989). The economic impact of the rheumatic diseases in the United States.
    29. (1998). The longterm outcomes of rheumatoid arthritis: Work disability:a prospective 18 year study of 823 patients.
    30. (2001). The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. Arthritis Rheum,
    31. (2004). TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infl iximab in southern Sweden. Ann Rheum Dis,
    32. (2006). Ultrasonographic and radiographic results from a two-year controlled trial of immediate or oneyear-delayed addition of infl iximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Arthritis Rheum,
    33. (2002). Which patients stop working because of rheumatoid arthritis? Results of fi ve years’ follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis,

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.